Found: 143
Select item for more details and to access through your institution.
Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 3, p. 1, doi. 10.1002/pds.5773
- By:
- Publication type:
- Article
Improving the accuracy of automated gout flare ascertainment using natural language processing of electronic health records and linked Medicare claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5684
- By:
- Publication type:
- Article
Validation of serostatus of rheumatoid arthritis using ICD‐10 codes in administrative claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 5, p. 586, doi. 10.1002/pds.5597
- By:
- Publication type:
- Article
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 467, doi. 10.1002/pds.5398
- By:
- Publication type:
- Article
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 2, p. 167, doi. 10.1002/pds.5356
- By:
- Publication type:
- Article
Validation of claims‐based algorithms to identify patients with psoriasis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 7, p. 868, doi. 10.1002/pds.5229
- By:
- Publication type:
- Article
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 770, doi. 10.1002/pds.4933
- By:
- Publication type:
- Article
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 757, doi. 10.1002/pds.4809
- By:
- Publication type:
- Article
Validation of claims‐based algorithms for psoriatic arthritis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 4, p. 404, doi. 10.1002/pds.4950
- By:
- Publication type:
- Article
A tool for empirical equipoise assessment in multigroup comparative effectiveness research.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 7, p. 934, doi. 10.1002/pds.4767
- By:
- Publication type:
- Article
Validation of claims-based algorithms for gout flares.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 7, p. 820, doi. 10.1002/pds.4044
- By:
- Publication type:
- Article
Identification of smoking using Medicare data--a validation study of claims-based algorithms.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 4, p. 472, doi. 10.1002/pds.3953
- By:
- Publication type:
- Article
Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 11, p. 1239, doi. 10.1002/pds.3520
- By:
- Publication type:
- Article
Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus.
- Published in:
- Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa027
- By:
- Publication type:
- Article
Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2023, v. 78, n. 12, p. 2426, doi. 10.1093/gerona/glad075
- By:
- Publication type:
- Article
Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2980, doi. 10.1111/dom.15196
- By:
- Publication type:
- Article
Validation of obesity‐related diagnosis codes in claims data.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2623, doi. 10.1111/dom.14512
- By:
- Publication type:
- Article
An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193622
- By:
- Publication type:
- Article
Assessment of coronary vascular function with cardiac PET in relation to serum uric acid.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192788
- By:
- Publication type:
- Article
Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score–Matched Cohort Study.
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 1, p. 52, doi. 10.1002/jbmr.4174
- By:
- Publication type:
- Article
Fracture Risk After Bariatric Surgery: Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 6, p. 1229, doi. 10.1002/jbmr.3101
- By:
- Publication type:
- Article
Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 3, p. 611, doi. 10.1002/jbmr.3019
- By:
- Publication type:
- Article
Gout and the Risk of Non-vertebral Fracture.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 2, p. 230, doi. 10.1002/jbmr.2978
- By:
- Publication type:
- Article
Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture.
- Published in:
- 2016
- By:
- Publication type:
- Other
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 8, p. 1729, doi. 10.1002/jbmr.1893
- By:
- Publication type:
- Article
Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc).
- Published in:
- BMC Endocrine Disorders, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12902-015-0044-z
- By:
- Publication type:
- Article
Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study.
- Published in:
- Rheumatology, 2022, v. 61, n. 1, p. 121, doi. 10.1093/rheumatology/keab294
- By:
- Publication type:
- Article
Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3789, doi. 10.1093/rheumatology/keaa862
- By:
- Publication type:
- Article
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis–associated interstitial lung disease among older rheumatoid arthritis patients.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3689, doi. 10.1093/rheumatology/keaa836
- By:
- Publication type:
- Article
Tuberculosis risk with biologics by screening-guided preventive strategy in rheumatoid arthritis under intermediate tuberculosis burden.
- Published in:
- Rheumatology, 2021, v. 60, n. 6, p. 2755, doi. 10.1093/rheumatology/keaa702
- By:
- Publication type:
- Article
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study.
- Published in:
- Rheumatology, 2019, v. 58, n. 12, p. 2122, doi. 10.1093/rheumatology/kez189
- By:
- Publication type:
- Article
Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention.
- Published in:
- Rheumatology, 2018, v. 57, p. v26, doi. 10.1093/rheumatology/kex523
- By:
- Publication type:
- Article
89-OR: Cardiovascular and Mortality Risk with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Inhibitors in Patients with Diabetic Retinopathy (DR).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-89-OR
- By:
- Publication type:
- Article
1431-P: Risk of Venous Thromboembolism amongst Initiators of SGLT2 Inhibitors Compared with Other Glucose-Lowering Agents.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1431-P
- By:
- Publication type:
- Article
925-P: Risk of Cardiovascular Events and Serious Hypoglycemia Comparing Patients with Type 2 Diabetes Initiating a GLP-1 Receptor Agonist or Basal Insulin: A Propensity-Score Matched Cohort Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-925-P
- By:
- Publication type:
- Article
35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-35-OR
- By:
- Publication type:
- Article
156-OR: Risk-Benefit of SGLT2 Inhibitors (SGLT2i) vs. GLP-1 Receptor Agonists (GLP-1RA) in Routine Care of Older Adults.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-156-OR
- By:
- Publication type:
- Article
1539-P: Assessing the Risk of Amputation with Canagliflozin in Middle-Aged Adults and Adults over 65 Years of Age: An Observational Study Using Three Nationwide Databases.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1539-P
- By:
- Publication type:
- Article
247-OR: Real-World Effectiveness of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in Patients With and Without Cardiovascular Disease.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-247-OR
- By:
- Publication type:
- Article
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01476-x
- By:
- Publication type:
- Article
Alendronate and Hip Fracture in Patients Using Glucocorticoids.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3723, doi. 10.1007/s12325-023-02533-x
- By:
- Publication type:
- Article
Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 11, p. 571, doi. 10.1002/acr2.11548
- By:
- Publication type:
- Article
Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drugs.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 8, p. 531, doi. 10.1002/acr2.11292
- By:
- Publication type:
- Article
Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 2, p. 72, doi. 10.1002/acr2.11218
- By:
- Publication type:
- Article
Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease‐Modifying Drugs: A Cohort Study.
- Published in:
- ACR Open Rheumatology, 2020, v. 2, n. 4, p. 222, doi. 10.1002/acr2.11124
- By:
- Publication type:
- Article
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020, v. 6, n. 1, p. 1, doi. 10.1002/trc2.12095
- By:
- Publication type:
- Article
Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 10, p. 1648, doi. 10.1002/art.42250
- By:
- Publication type:
- Article
Trends in Utilization of Urate‐Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 3, p. 542, doi. 10.1002/art.41550
- By:
- Publication type:
- Article
Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors After the Introduction of Biosimilar Infliximab in the United States.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 6, p. 1036, doi. 10.1002/art.41201
- By:
- Publication type:
- Article